D-0154-2024 Class II Ongoing

Recalled by Fagron, Inc — Saint Paul, MN

FDA drug recall D-0154-2024 was initiated by Fagron, Inc on Dec 11, 2023 and is designated Class II. Reason for recall: Labeling: Label Error on Declared Strength: Assay value on the label is incorrect. The recall status is ongoing. Affected quantity: 13 containers.

Recall details

Product Type
Drugs
Report Date
Dec 27, 2023
Initiation Date
Dec 11, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13 containers

Product description

NYSTATIN 5BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, Inc. - 2400 Pilot Knob Rd. St Paul, MN 55120. NDC 51552-0041-5 Bar code 3 51552 00415 3

Reason for recall

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Distribution pattern

Product was distributed to 1 distributor and may have further distributed the product to repacker/relabelers and pharmacies in the United States and Canada to be used for prescription compounding.

Code information

Lot#: 230308-U46196, Exp. date 04/30/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0154-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0154-2024. Report a data issue: hello@regdatalab.com.